Give Us A Call



Send Us An Email


Medically Assisted Treatment


Medication Assisted Detox and Treatment


Medication-assisted treatment (MAT) is the use of medications with counseling and behavioral therapies to treat substance use disorders and prevent opioid overdose. Research shows that a combination of medication and therapy can successfully treat opioid use disorders, and for some people, MAT can help sustain long term recovery.
MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates. The prescribed medication operates to normalize brain chemistry, block the euphoric effects of opioids, relieve physiological cravings, and normalize body functions without the negative effects of the abused drug. Medications used in MAT are approved by the Food and Drug Administration (FDA), and MAT programs are clinically driven and tailored to meet each patient’s needs.


Call to Discover More about our Medically Assisted Detox and Treatment Program



There are three drugs approved by the FDA for the treatment of opioid dependence: buprenorphine, methadone, and naltrexone. All three of these treatments have been demonstrated to be safe and effective in combination with counseling and psychosocial support. Due to the chronic nature of opioid use disorder, the need for continuing MAT should be re‐evaluated periodically. There is no maximum recommended duration of maintenance treatment, and for some patients, treatment may continue indefinitely.

In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder. If you or a loved one are struggling with an opioid use disorder, medication- assisted treatment might be the help you need. MAT provides a more comprehensive, individually tailored program of medication and behavioral therapy. MAT also includes support services that address the needs of most patients.


Insurance Verification Form

3 + 14 =

The ultimate goal of MAT is full recovery. This treatment approach has been shown to:
Improve patient survival
Increase retention in treatment
Decrease illicit opiate use and other criminal activity among people with substance use disorders
Increase patients’ ability to gain and maintain employment
Improve birth outcomes among women who have substance use disorders and are pregnant
Research also shows that these medications and therapies can contribute to lowering a person’s risk of contracting HIV or hepatitis C by reducing the potential for relapse.



FDA-approved buprenorphine products approved for the treatment of opioid dependence include:

Suboxone (buprenorphine and naloxone) sublingual film for sublingual or buccal use
Subutex (buprenorphine and naloxone) sublingual film or tablet
Zubsolv (buprenorphine and naloxone) sublingual tablets
Bunavail (buprenorphine and naloxone) buccal film
Cassipa (buprenorphine and naloxone) sublingual film
Probuphine (buprenorphine) implant for subdermal administration
Sublocade (buprenorphine extended‐release) injection for subcutaneous use

FDA-approved methadone products approved for the treatment of opioid dependence include:
Dolophine (methadone hydrochloride) tablets
Methadose (methadone hydrochloride) oral concentrate

FDA-approved naltrexone products approved for the treatment of opioid dependence include:
Vivitrol (naltrexone for extended-release injectable suspension) intramuscular

Call Now - Get Help Now

The Bridges to Life Detox and Recovery team is ready to answer your questions and provide help today.
Get Help Now